CRP ultrasensible, deux approches

Grandjean, F.; Berlage, V.; Auger, L.; Robert, F.; Vankerkhoven, P.; Cirriez, J.-M.

doi:10.1016/j.immbio.2006.04.001

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The link of these circulating levels to a large number of cardiovascular risk factors such as obesity, dyslipidemia, resistance to the action of insulin, type 2 diabetes, arterial hypertension both in both children and adults has been widely demonstrated [26] [27] [28] [29] [30] [31]. The hsCRP assay can detect low CRP concentrations below 0.1 mg/L [32]. Its dosage in the laboratory can be done using rapid, low cost techniques with the possibility of using a standard analyzer.…”

Section: Discussionmentioning

confidence: 99%

Contribution of High Sensible C-Reactive Protein (hsCRP) in the Assessment of the Risk of Onset of Type 2 Diabetes and Its Cardiovascular Complications

Touré,

Sène,

Diagne

et al. 2024

JDM

View full text Add to dashboard Cite

Background: Type 2 diabetes is a metabolic disease characterized by chronic hyperglycemia. The latter plays an essential role in inflammation by stimulating the production of pro-inflammatory cytokines or by increasing their secretion by an oxidative mechanism. These cytokines control the hepatic synthesis of an inflammatory protein called C-Reactive Protein (CRP). High or average values of CRP would have a predictive value of cardiovascular diseases and type 2 diabetes. The relationship between low CRP values and the risk of developing type 2 diabetes and its cardiovascular complications is not sufficiently studied. The hsCRP could serve as a predictive biomarker of risk of onset, follow-up and prognosis for type 2 diabetes and its cardiovascular complications. To answer this problem, we conducted this study, the aim of which was to study the predictive role of hsCRP in the risk of occurrence of type 2 diabetes and its cardiovascular complications. Materials and Methods: This is a prospective and cross-sectional case-control study involving 200 participants including 100 control women and 100 women with type 2 diabetes (mean age was respectively 49.

show abstract